Life Sciences market research reports by Quaintel Research

• Carl Zeiss AG - Strategic SWOT Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends

  Aug 23, 2024  |  Published by: Quaintel Research  |  USD 150

  Carl Zeiss AG - Strategic SWOT Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report Summary Carl Zeiss AG - Strategic SWOT Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Str ... Read More

• Baxter International Inc. (BAX:NYSE) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends

  Aug 12, 2024  |  Published by: Quaintel Research  |  USD 175

  Baxter International Inc. (BAX:NYSE) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report Summary Baxter International Inc. (BAX:NYSE) Strategic SWOT, PESTLE Anal ... Read More

• Becton, Dickinson and Company (BDX:NYSE) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends

  Aug 12, 2024  |  Published by: Quaintel Research  |  USD 175

  Becton, Dickinson and Company (BDX:NYSE) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report Summary Becton, Dickinson and Company (BDX:NYSE) Strategic SWOT, PES ... Read More

• Medtronic plc (MDT:NYSE) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends

  Aug 12, 2024  |  Published by: Quaintel Research  |  USD 175

  Medtronic plc (MDT:NYSE) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report Summary Medtronic plc (MDT:NYSE) Strategic SWOT, PESTLE Analysis and Financial Insig ... Read More

• ResMed Inc. (RMD:NYSE) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI’s, and Recent Trends

  Jul 12, 2024  |  Published by: Quaintel Research  |  USD 175

  ResMed Inc. (RMD:NYSE) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI’s, and Recent Trends Report Summary ResMed Inc. (RMD:NYSE) Strategic SWOT, PESTLE ... Read More

• Trinity Health Corp. Strategic SWOT and PESTLE Analysis - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends

  Jun 10, 2024  |  Published by: Quaintel Research  |  USD 175

  Trinity Health Corp. Strategic SWOT and PESTLE Analysis - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report Summary Trinity Health Corp Strategic SWOT and PESTLE Analysis - A 360° Review of Opportunities, Challenges ... Read More

• LHC Group Inc. Strategic SWOT and PESTLE Analysis - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends

  Jun 10, 2024  |  Published by: Quaintel Research  |  USD 175

  LHC Group Inc. Strategic SWOT and PESTLE Analysis - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report Summary LHC Group Inc. Strategic SWOT and PESTLE Analysis - A 360° Review of Opportunities, Challenges and Risk, C ... Read More

• Phoenix Pharmahandel GmbH & Co KG Strategic SWOT and PESTLE Analysis - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends

  Jun 10, 2024  |  Published by: Quaintel Research  |  USD 175

  Phoenix Pharmahandel GmbH & Co KG Strategic SWOT and PESTLE Analysis - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report Summary Phoenix Pharmahandel GmbH & Co KG Strategic SWOT and PESTLE Analysis - A 360° Review of ... Read More

• Health Care Service Corporation Strategic SWOT and PESTLE Analysis - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends

  Jun 10, 2024  |  Published by: Quaintel Research  |  USD 175

  Health Care Service Corporation Strategic SWOT and PESTLE Analysis - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report Summary Health Care Service Corporation Strategic SWOT and PESTLE Analysis - A 360° Review of Opp ... Read More

• University of Pittsburgh Medical Center Strategic SWOT and PESTLE Analysis - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends

  Jun 10, 2024  |  Published by: Quaintel Research  |  USD 175

  University of Pittsburgh Medical Center Strategic SWOT and PESTLE Analysis - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report Summary University of Pittsburgh Medical Center Strategic SWOT and PESTLE Analysis - A 36 ... Read More

• Boehringer Ingelheim International GmbH : Strategic SWOT and PESTLE Analysis - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends

  May 10, 2024  |  Published by: Quaintel Research  |  USD 175

  Boehringer Ingelheim International GmbH : Strategic SWOT and PESTLE Analysis - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report Summary Boehringer Ingelheim International GmbH : Strategic SWOT and PESTLE Analysis - ... Read More

• B.Braun Melsungen AG Strategic SWOT and PESTLE Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends

  Apr 08, 2024  |  Published by: Quaintel Research  |  USD 175

  B.Braun Melsungen AG Strategic SWOT and PESTLE Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report Summary B.Braun Melsungen AG Strategic SWOT and PESTLE Insights - A 360° Review of Opportunities, Challenges ... Read More

• Cardinal Health Inc (CAH:NYSE) Strategic and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI’s, and Recent Trends

  Mar 11, 2024  |  Published by: Quaintel Research  |  USD 175

  Cardinal Health Inc (CAH:NYSE) Strategic and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI’s, and Recent Trends Report Summary Cardinal Health Inc (CAH:NYSE) Strategic and Financial Ins ... Read More

• CommonSpirit Health Strategic SWOT and PESTLE Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends

  Mar 11, 2024  |  Published by: Quaintel Research  |  USD 175

  CommonSpirit Health Strategic SWOT and PESTLE Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report Summary CommonSpirit Health Strategic SWOT and PESTLE Insights - A 360° Review of Opportunities, Challenges ... Read More

• UnitedHealth Group Inc (UNH:NYSE) Strategic SWOT, PESTLE, Value Chain Analysis and Financial Insight - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI’s, and Recent Trends

  Feb 01, 2024  |  Published by: Quaintel Research  |  USD 225

  UnitedHealth Group Inc (UNH:NYSE) Strategic SWOT, PESTLE, Value Chain Analysis and Financial Insight - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI’s, and Recent Trends Report Summary UnitedHealth Group Inc ... Read More

• Amgen, Inc. (AMGN:NASD) Strategic SWOT, PESTLE, Value Chain Analysis and Financial Insight - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI’s, and Recent Trends

  Feb 01, 2024  |  Published by: Quaintel Research  |  USD 225

  Amgen, Inc. (AMGN:NASD) Strategic SWOT, PESTLE, Value Chain Analysis and Financial Insight - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI’s, and Recent Trends Report Summary Amgen, Inc. (AMGN:NASD) Strategi ... Read More

• Abbott Laboratories (ABT:NYSE) Strategic SWOT, PESTLE and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI’s, and Recent Trends

  Nov 30, 2023  |  Published by: Quaintel Research  |  USD 175

  Abbott Laboratories (ABT:NYSE) Strategic SWOT, PESTLE and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI’s, and Recent Trends Report Summary Abbott Laboratories (ABT:NYSE) Strategic SWOT, ... Read More

< prev 1 2 3 next >